Latest Breaking News On - வெட்டு உயிரியல் - Page 1 : comparemela.com

Inozyme Pharma Expands its Scientific Advisory Board

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Inozyme Pharma Expands its Scientific Advisory Board Inozyme Pharma Inc.April 1, 2021 GMT BOSTON, April 01, 2021 (GLOBE NEWSWIRE) Inozyme Pharma, Inc., a rare disease biopharmaceutical company developing novel therapeutics for the treatment of disorders of abnormal mineralization, announced today changes to its scientific advisory board (SAB), including the addition of three leading key opinion leaders with specific expertise in the company’s lead indications: W Charles O’Neill IV, M.D., Director of the Ultrasonography Program in the Renal Division at Emory University School of Medicine

United statesSan diegoInozyme pharmaEd skolnikAlex van reesCharles oneillDavid thompsonW charles oneillPseudoxanthoma elasticumMarka lemmonJouni uittoRobert terkeltaubYves sabbaghFrank rutschMichaela levineJoseph schlessinger

Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across . INNATE PHARMAFebruary 3, 2021 GMT MARSEILLE, France, Feb. 03, 2021 (GLOBE NEWSWIRE) Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that it will host a virtual key opinion leader (KOL) discussion focused on the potential role of its lead investigational drug candidate, lacutamab, an anti-KIR3DL2 cytotoxicity-inducing antibody in development for T-cell lymphomas. The event will be held virtually on Tuesday, February 9, 2021 at 2:00 p.m. CET / 8:00 a.m. ET.

Universitaire necker enfants maladesPierluigi porcuBristol myers squibbNovo nordiskOlivier hermineDivision of hematologic malignanciesUniversity of paris descartesDivision of adult hematologyExchange commissionFrench financial markets authorityCompany annual report on formMember of the lymphoma study associationEuronext parisMedical oncologyCutaneous biologyHematologic malignancies

Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across T-Cell LymphomasVirtual event to take place at 2:00 p m CET / 8:00 a m ET on Tuesday, February 9, 2021

Published: Feb 03, 2021 Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“ Innate” or the “ Company”) today announced that it will host a virtual key opinion leader (KOL) discussion focused on the potential role of its lead investigational drug candidate, lacutamab, an anti-KIR3DL2 cytotoxicity-inducing antibody in development for T-cell lymphomas. The event will be held virtually on Tuesday, February 9, 2021 at 2:00 p.m. CET / 8:00 a.m. ET. The event will feature presentations from the Company’s executive leadership team, as well as the following KOLs: Pierluigi Porcu, M.D., Professor of Medical Oncology, Dermatology and Cutaneous Biology and Director, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation at Thomas Jefferson University, US; Principal Investigator of Innate’s Phase 2 TELLOMAK clinical trial, which is evaluating lacutamab in mycosis fungoides and Sézary syndrome; and

Universitaire necker enfants maladesPierluigi porcuBristol myers squibbNovo nordiskOlivier hermineDivision of hematologic malignanciesUniversity of paris descartesDivision of adult hematologyExchange commissionFrench financial markets authorityCompany annual report on formMember of the lymphoma study associationEuronext parisMedical oncologyCutaneous biologyHematologic malignancies

Predicting heart disease from the skin

E-Mail PHILADELPHIA - Our skin tells us when we ve spent too much time in the sun or when the dry air of winter has sucked away too much moisture. Now Jefferson researchers find that the skin can also foretell issues unrelated to the protective barrier. An international team of researchers led by Jouni Uitto, MD, PhD, a Professor of Dermatology and Cutaneous Biology, report that mutations in a gene known to underlie a rare skin disorder also lead to a serious heart disease. The findings are the latest example from Dr. Uitto s laboratory to show that when combined with genetic analysis, the skin may help to predict future medical conditions.

United statesJouni uittoAmir hossein saeidianLu liuFatemeh niaziorimiMasoomeh faghankhaniFatemeh rajabiLiaosadat mirsafaeiHassan vahidnezhadNikoo mozafariAriana kariminejadSoheila sotoudehJohna mcgrathFahimeh abdollahimajdLeila youssefianZahra alizadeh sani

Researchers find that the genetic underpinnings of a skin disorder at birth indicate future heart problems

Researchers find that the genetic underpinnings of a skin disorder at birth indicate future heart problems
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Jouni uittoHassan vahidnezhadLeila youssefianSidney kimmel medical collegeCutaneous biologyRight ventricular cardiomyopathySkin fragilityசிட்னி கீம்மேல் மருத்துவ கல்லூரிவெட்டு உயிரியல்